“This study demonstrated that Seraph®-100 adsorbed three bacteria from a super-infected solution during an in vitro simulated hemoperfusion session, suggesting a new era in treating bloodstream infections caused by several pathogens, often inducing sepsis.” via MDPI https://lnkd.in/ev8pTjft
ExThera Medical
Medical Device
Martinez, CA 2,403 followers
Our Vision Is To Make Life-Threatening Bloodstream Infections A Thing Of The Past.
About us
ExThera Medical develops revolutionary medical devices that address unmet clinical needs in the treatment of bloodstream infections. ExThera has developed a first-of-its-kind blood filter designed to reduce pathogens during bloodstream infections. Harmful substances are captured and adsorbed onto the device’s proprietary surface. Their concentration in the bloodstream is thereby reduced without adding anything to the treated blood, which is then returned to the patient with blood cells intact.
- Website
-
http://www.extheramedical.com
External link for ExThera Medical
- Industry
- Medical Device
- Company size
- 11-50 employees
- Headquarters
- Martinez, CA
- Type
- Privately Held
- Founded
- 2008
- Specialties
- Medical Devices, Blood Purification, Bloodstream Infections, Antibiotic Resistance, Sepsis, and COVID-19
Locations
-
Primary
Get directions
757 Arnold Drive, Suite B
Martinez, CA 94553, US
Employees at ExThera Medical
-
Deven D. Parghi
Sr Medical Device Program Manager
-
Michael DiMeo
CFO | Interim CFO | Private Equity | Fortune 100 | Independent Director | Life Sciences | Biotech
-
Mick Kostal
Area Sales Manger
-
Greg Dollarhyde
Director Emeritus: EXTHERA MEDICAL, Director: BLAZE PIZZA, STARBIRD CHICKEN and Former Chairman & CEO of ZOES KITCHEN, Ex- Chairman and director of…
Updates
-
ExThera Medical Announces Formation of New Business Advisory Board https://lnkd.in/gBkSrNHk
-
-
The Seraph® 100 Microbind® Affinity blood filter has been in use since 2019 for the treatment of fulminant or difficult to treat blood stream infections as an adjunct to pharmacotherapy. Learn more: https://lnkd.in/eZ24kUBh (Sage) And for more news visit: https://lnkd.in/ev8pTjft #nephrology #Hemoperfusion #healthcare #seraph100 #criticalcare
-
-
This research article describes two chronic critically ill patients who developed secondary viral bloodstream infections successfully treated with the Seraph 100 hemoperfusion cartridge. Learn more: https://lnkd.in/gkXd6zYe (Sage) And for more news visit: https://lnkd.in/ev8pTjft #nephrology #hemoperfusion #healthcare #seraph100 #criticalcare
-
-
Prospective, observational study of 34 participants undergoing treatment with the Seraph 100 blood filter at 6 participating sites in the United States in Europe PMC. Learn more: https://lnkd.in/gM3ADmgp And for more news visit: https://lnkd.in/ev8pTjft #antibiotics #nephrology #Hemoperfusion #healthcare #seraph100 #criticalcare
-
-
A key conclusion of the case report in Critical Care Explorations: “This is the first reported use of VA-ECMO, Seraph 100 hemoperfusion, and cell-directed immunomodulation with SCD. This multimodal approach to extracorporeal support represents a promising therapeutic strategy for the most refractory critical care cases.” Learn more: https://lnkd.in/gKeqkaRv And for more news visit: https://lnkd.in/ev8pTjft #casereport #extracorporealtherapy #sepsis #seraph100 #healthcare #criticalcare
-
-
ExThera Medical Corporation announces that it has received multiple Breakthrough Device Designations from the U.S. Food and Drug Administration (FDA), for its Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100). Learn more 👉https://lnkd.in/ggaBfMq3 #healthcare
-
-
Seraph® 100 Microbind® Affinity Blood Filter Deemed First-In-Class Medical Device by U.S. FDA Learn more 👉https://lnkd.in/ggaBfMq3 #healthcare #medicaldevices #covid19 #medicalsciences
-
-
FDA Grants ExThera Multiple Breakthrough Device Designations for its Seraph® 100 Filter Learn more 👉https://lnkd.in/ggaBfMq3 #healthcare #medicaldevices #medicalsciences #healthcareindustry
-
-
ExThera Medical Announces FDA Approval of IDE Application for Use of the OncoBind™ Extracorporeal Procedure to Remove Circulating Tumor Cells in Patients with Pancreatic Cancer Learn more 👉 https://lnkd.in/g2_TC5zq
-